NL Holding has sold a 30% stake to Oaktree Capital, while simultaneously acquiring fertility providers and specialised diagnostic laboratories in Switzerland, Italy and Spain. This coincides with Oaktree offloading its pan-European dentistry platform. We take a more detailed look at what NL has bought.